Boston University

Newly launched aggregator Seqster will help Boston University researchers collect data from EHRs, wearables, and gene tests to identify concussion biomarkers.

Six microRNAs appeared to be present at enhanced levels in cerebrospinal fluid from symptom-free individuals with characteristic Huntington disease gene expansions.

The initiative's four research projects will use use genetic and other technologies to detect and treat cancer at its earliest stages.

Eleven new studies from the NHLBI NextGen Consortium show different uses for iPSCs to study polygenetic diseases across various systems in the human body.

This Week in Cell

In Cell this week: genomic events that could make attenuated polio virulent, formation of regulatory RNAs, and more.

The investigators will conduct a longitudinal study of former athletes with high and medium exposure to repetitive head trauma, including former NFL players.

Public health researchers argue in NEJM that precision medicine initiatives will take away from needed efforts to improve population health.

Aperiomics launched its commercial sequencing and bioinformatics-based pathogen detection service at the annual meeting of the Association for Molecular Pathology last week, with three offerings: Absolute-ID, Absolute-Discovery, and Absolute-Biome.

NEW YORK (GenomeWeb) — A US-Israeli team has developed an improved optical method for reading out the ion current through solid-state nanopores, providing an alternative to present approaches for nanopore sequencing that use electrical measurements.

Packaging isothermal PCR reagents in blisters and using lateral flow detection, researchers at Boston University hope to develop a low-cost, disposable assay for Bordetella pertussis, the causative agent of whooping cough.


An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.